Literature DB >> 1512920

The effect of levofloxacin, an optically-active isomer of ofloxacin, on fecal microflora in human volunteers.

Y Inagaki1, R Nakaya, T Chida, S Hashimoto.   

Abstract

Following oral administration of levofloxacin (LVFX, (S)-(-)-Ofloxacin; formerly designated as DR-3355) at 200 mg per dose 3 times a day for 7 days to 6 healthy male volunteers, degrees of disturbance of the fecal microflora and fecal drug concentrations were examined. The total viable count remained unchanged during the study period due to the minimal change in the number of members of the family Bacteroidaceae, the most predominant organisms. Most of the aerobes including facultative anaerobes were suppressed by LVFX with only a slight increase in yeasts. In particular, the members of the family Enterobacteriaceae were reduced to below the detection limit on and after day 3 through the time of discontinuation of the drug in all subjects but one. Among the obligate anaerobes, peptostreptococci and bifidobacteria decreased or disappeared in some volunteers, but no significant changes were observed in other anaerobes. Neither Clostridium difficile nor its toxin D-1 was detected in any of the volunteers. No side effects attributable to the drug were observed. During administration, LVFX was detected in the feces at high concentrations which correlated well with the decrease of susceptible members of flora as well as to their detection rate.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1512920

Source DB:  PubMed          Journal:  Jpn J Antibiot        ISSN: 0368-2781


  6 in total

Review 1.  The clinical pharmacokinetics of levofloxacin.

Authors:  D N Fish; A T Chow
Journal:  Clin Pharmacokinet       Date:  1997-02       Impact factor: 6.447

Review 2.  Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy.

Authors:  R Davis; H M Bryson
Journal:  Drugs       Date:  1994-04       Impact factor: 9.546

Review 3.  Impact of antimicrobial therapy on the gut microbiome.

Authors:  Amira A Bhalodi; Tjitske S R van Engelen; Harjeet S Virk; W Joost Wiersinga
Journal:  J Antimicrob Chemother       Date:  2019-01-01       Impact factor: 5.790

4.  Antimicrobial Resistance Gene Prevalence in a Population of Patients with Advanced Dementia Is Related to Specific Pathobionts.

Authors:  Aislinn D Rowan-Nash; Rafael Araos; Erika M C D'Agata; Peter Belenky
Journal:  iScience       Date:  2020-02-13

Review 5.  Oxygen and Metabolism: Digesting Determinants of Antibiotic Susceptibility in the Gut.

Authors:  Lauren R Heinzinger; Angus Johnson; Jenna I Wurster; Rachael Nilson; Swathi Penumutchu; Peter Belenky
Journal:  iScience       Date:  2020-11-30

6.  The effect of antibiotics on the clinical outcomes of patients with solid cancers undergoing immune checkpoint inhibitor treatment: a retrospective study.

Authors:  Hyunho Kim; Ji Eun Lee; Sook Hee Hong; Myung Ah Lee; Jin Hyoung Kang; In-Ho Kim
Journal:  BMC Cancer       Date:  2019-11-12       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.